Entrada Therapeutics Growth Metrics (2021-2026) | TRDA

Growth Metrics Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) 5,859.0014,612.00-14271.00-2741.00-14170.00-245893.00-280451.00-323358.00-472864.00
EBITDA Margin Growth (3y) (Quarter) -481175.00
EBITDA Margin (QoQ) (Quarter) -6682.0012,174.00-2032.002,399.002,070.00-16709.009,498.00-9030.00-229652.00-51267.00-33409.00-158536.00
EBIT Margin Growth (1y) (Quarter) 5,859.0014,612.00-14271.00-2741.00-14170.00-245893.00-280451.00-323358.00-472864.00
EBIT Margin Growth (3y) (Quarter) -481175.00
EBIT Margin (QoQ) (Quarter) -6682.0012,174.00-2032.002,399.002,070.00-16709.009,498.00-9030.00-229652.00-51267.00-33409.00-158536.00
EBT Margin Growth (1y) (Quarter) 5,520.0012,752.00-12251.00-2395.00-12723.00-226231.00-261272.00-300588.00-445035.00
EBT Margin Growth (3y) (Quarter) -452238.00
EBT Margin (QoQ) (Quarter) -5413.0010,779.00-1932.002,086.001,819.00-14223.007,923.00-8241.00-211689.00-49265.00-31392.00-152689.00
Enterprise Value Growth (1y) (Quarter) -645.46%-76.41%84.49%13.74%67.35%75.93%-49.70%69.94%-132.31%-50.44%-49.72%0.88%60.87%-19.52%10.04%-12.69%
Enterprise Value Growth (3y) (Quarter) -20.08%13.88%29.68%36.42%33.30%24.36%-26.33%30.49%
Enterprise Value Growth (5y) (Quarter) -18.45%
Enterprise Value (QoQ) (Quarter) -138.19%9.33%7.45%11.74%79.05%-404.13%64.97%34.94%-30.30%-1.23%-170.70%57.87%-29.68%32.97%-6.85%-28.70%2.39%16.04%
FCF Margin Growth (1y) (Quarter) -81440.0019,070.00-3935.00-8650.00-14448.00-154256.00-164806.00-238996.00-457731.00
FCF Margin Growth (3y) (Quarter) -553619.00
FCF Margin (QoQ) (Quarter) -92155.008,593.005,265.00-3144.008,356.00-14412.00550.00-8941.00-131452.00-24962.00-73639.00-227677.00
Interest Coverage Ratio Growth (1y) (Quarter) 2.41%-22.05%815.39%-64.89%78.49%281.38%-108.17%7,089.48%95,178.89%-170,626.61%74.98%-317.20%-371.55%3.45%-1,345.26%
Interest Coverage Ratio Growth (3y) (Quarter) 17.08%-1,457.06%47.32%-530.23%-721.96%-1,340.06%-1,199.41%
Interest Coverage Ratio (QoQ) (Quarter) 11.07%-1.85%-13.91%-18.28%621.28%-123.48%85.14%1,097.39%-123.47%20,193.23%102.14%-1,888.85%100.00%-174,341.29%-152.72%-536.06%
Net Margin Growth (1y) (Quarter) 6,616.0020,077.00-15279.002,573.00-12413.00-226961.00-266275.00-301857.00-445470.00
Net Margin Growth (3y) (Quarter) -451266.00
Net Margin (QoQ) (Quarter) -11628.0022,378.00-10379.006,245.001,833.00-12977.007,473.00-8741.00-212715.00-52291.00-28110.00-152354.00
Operating Margin Growth (1y) (Quarter) 5,859.0014,612.00-14271.00-2741.00-14170.00-245893.00-280451.00-323358.00-472864.00
Operating Margin Growth (3y) (Quarter) -481175.00
Operating Margin (QoQ) (Quarter) -6682.0012,174.00-2032.002,399.002,070.00-16709.009,498.00-9030.00-229652.00-51267.00-33409.00-158536.00
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.00-1.00
Return on Assets Growth (3y) (Quarter) 1.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -1623.00-1547.00675.002,380.003,931.004,491.004,080.002,199.001,038.00-667.00-4176.00-4149.00-5198.00-5374.00
Return on Capital Employed Growth (3y) (Quarter) 3,346.002,277.00578.00431.00-229.00-1550.00
Return on Capital Employed (QoQ) (Quarter) 214.00-532.00-693.00-612.00290.001,690.001,013.00939.00850.001,278.00-868.00-223.00-854.00-2232.00-841.00-1272.00-1031.00
Return on Sales Growth (1y) (Quarter) 1.002.00-2.000.00-1.00-23.00-27.00-30.00-45.00
Return on Sales Growth (3y) (Quarter) -45.00
Return on Sales (QoQ) (Quarter) -1.002.00-1.001.000.00-1.001.00-1.00-21.00-5.00-3.00-15.00